Clinical trial
FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing…
NCT00424138 · American College of Radiology Imaging Network, Other · Terminated
Key facts
| NCT number | NCT00424138 |
|---|---|
| Title | FDG-PET/CT Scans in Patients With Stage IIIB or Stage IV NSCLC Undergoing Chemotherapy |
| Official title | [18F]FDG-PET/CT as a Predictive Marker of Tumor Response and Patient Outcome: Prospective Validation in Non-Small Cell Lung Cancer |
| Acronym | ACRIN6678 |
| Lead sponsor | American College of Radiology Imaging Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Radiation |
| Interventions | FDG |
| Enrollment | 96 |
| Start date | Mar 30, 2007 |
| Primary completion | Aug 31, 2011 |
| Completion | Aug 31, 2011 |
| First posted | Jan 18, 2007 |
| Last update posted | Oct 11, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: